Get the Stockscreener App
2.83
3.41%
-0.10
Aethlon Medical Inc stock is traded at $2.83, with a volume of 36,759.
It is down -3.41% in the last 24 hours and up +313.14% over the past month.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
See More
Previous Close:
$2.93
Open:
$2.93
24h Volume:
36,759
Relative Volume:
0.06
Market Cap:
$1.49M
Revenue:
$574.20K
Net Income/Loss:
$-7.15M
P/E Ratio:
-0.1782
EPS:
-15.8778
Net Cash Flow:
$-7.00M
1W Performance:
-10.16%
1M Performance:
+313.14%
6M Performance:
+44.39%
1Y Performance:
+141.88%
1-Day Range:
$2.78
$3.05
1-Week Range:
$2.78
$3.20
52-Week Range:
$0.5079
$5.89
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
2.83 | 1.60M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
111.25 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
339.21 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.27 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.83 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.60 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | H.C. Wainwright | Neutral |
Aethlon Medical Inc Stock (AEMD) Latest News
Aethlon Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Aethlon Medical posts Q1 2026 loss miss as trial advances - Investing.com
Aethlon Medical Q1 Results: EPS misses estimate, losses widen - scanx.trade
Aethlon Medical Advances Hemopurifier Trials and Bolsters Liquidity - TipRanks
AETHLON MEDICAL ($AEMD) Releases Q1 2027 Earnings - quiverquant.com
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program - Yahoo Finance
Aethlon Medical (AEMD) investors disclose 55,556-share warrant position, 2.3% stake - Stock Titan
Q3 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Q1 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Asset turnover of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Inventory turnover of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Total assets of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Net income before discontinued operations of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
AEMD Q1'26 Earnings: EPS estimate is (3.92) USD - TradingView
Aethlon Medical Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView
Aethlon Medical (AEMD.US) will release its earnings report after market close on August 13. - Moomoo
Stock splits calendar for: - Yahoo Finance UK
Aethlon Medical schedules Aug. 13 call on quarter ended June 30 - Stock Titan
Aethlon Medical to report Q1 2026 financial res... - Pluang
Stock Splits Calendar for: - Yahoo! Finance Canada
Market Movers | Winners: AEMD, HYFM, FUSE | Losers: GYGY, CALC, MIRA - Trefis
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
Aethlon Medical To Carry Out 1-for-5 Reverse Stock Split On August 4th, 2026 - Moomoo
Aethlon Medical Announces Reverse Stock Split Implementation - TipRanks
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Aethlon Medical, Inc. Revenue Breakdown – NASDAQ:AEMD - TradingView
AEMD|Aethlon Medical Inc|Price:0.585|Chg%:-0.016 - TradingKey
Aethlon Medical (AEMD) Dips 3.4% to $0.63 as Small-Cap Biotech Faces Persistent Selling PressureIntraday Profile - dars.gov.et
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Aethlon Medical at emerging growth conference: trial data and cash boost - Investing.com
AEMD: Hemopurifier shows early promise in oncology trials, with strong platform and financial position - TradingView
Aethlon Medical Reports Encouraging Hemopurifier Trial Results - t.co
Aethlon Medical (AEMD) Gains 2.39% as Stock Approaches $0.70 Resistance LevelSentiment Extreme - dars.gov.et
Aethlon Medical reports second cohort results from cancer study - Investing.com UK
Aethlon Medical (AEMD) Slides 5.4% as Pressure Mounts Near Key Support LevelEarnings Beat Stocks - dars.gov.et
Aethlon Medical advances Hemopurifier oncology study to third cohort - grafa.com
Aethlon Medical reports second cohort results from cancer study By Investing.com - Investing.com South Africa
Experimental cancer filter shows repeat immune and tumor-signal shifts in small Australian study - Stock Titan
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier® - Yahoo Finance
Aethlon Medical Inc. (AEMD) Q2 2026 Earnings: Narrower Loss Exceeds ExpectationsPretax Income Report - DonanımHaber
Aethlon Medical Announces $4 Million At-the-Market Offering to Advance Cancer and Infectious Disease Therapies - Minichart
Aethlon Medical Announces July 2026 Financing Offering - TipRanks
Aethlon Medical (NASDAQ: AEMD) prices $4M follow-on at-the-market deal - Stock Titan
Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent - TradingView
Aethlon Medical | 8-K: Current report - Moomoo
Aethlon Medical (AEMD) launches $0.71 unit offering registering 11.2M shares - Stock Titan
[EFFECT] AETHLON MEDICAL INC SEC Filing - Stock Titan
Aethlon Medical Inc. (AEMD) Q2 2026 Earnings: Narrower-Than-Expected Loss Drives Stock HigherRetail Earnings Report - dars.gov.et
AEMDAethlon Medical Inc Latest SEC Filings - Finviz
Aethlon Medical prices $4M follow-on offering at $0.7101 - scanx.trade
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):